六块爱理不理 8块高攀不起查看全文
格隆汇11月15日丨Aytu BioPharma(AYTU.US)盘前涨18.76%,报0.23美元。公司2023年Q1财报实现营收2765.5万美元,前值为2189.7万美元,预期值为2430万美元,超出市场预期13.81%;每股收益为-0.06美元,前值为-0.33美元,预期值为-0.18美元,超出市场预期66.67%。 网页链接
$Aytu BioScience(AYTU)$ 8-K/A [Amend] Current report, items 2.01 and 9.01 Accession Number: 0001213900-20-000798 Act: 34 Size: 566 KB 网页链接
$Aytu BioScience(AYTU)$ 425 Prospectuses and communications, business combinations Accession Number: 0001213900-20-000799 Act: 34 Size: 567 KB 网页链接
$Aytu BioScience(AYTU)$ 424B3 Prospectus [Rule 424(b)(3)] Accession Number: 0001213900-20-000776 Act: 33 Size: 170 KB 网页链接
$Aytu BioScience(AYTU)$ S-3/A [Amend] Registration statement under Securities Act of 1933 Accession Number: 0001213900-19-027282 Act: 33 Size: 243 KB 网页链接
$Aytu BioScience(AYTU)$ 8-K Current report, items 7.01 and 9.01 Accession Number: 0001654954-19-014200 Act: 34 Size: 58 KB 网页链接
$Aytu BioScience(AYTU)$ S-4 Registration of securities, business combinations Accession Number: 0001213900-19-026858 Act: 33 Size: 6 MB 网页链接
$Aytu BioScience(AYTU)$ DEF 14A Other definitive proxy statements Accession Number: 0001213900-19-026847 Act: 34 Size: 488 KB 网页链接
$Aytu BioScience(AYTU)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000919574-19-007770 Size: 14 KB 网页链接
$Aytu BioScience(AYTU)$ S-3/A [Amend] Registration statement under Securities Act of 1933 Accession Number: 0001213900-19-026676 Act: 33 Size: 250 KB 网页链接
$Aytu BioScience(AYTU)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001654954-19-014096 Size: 5 KB 网页链接